Archives

by in
Entry Author Date Location
Houston-Based Healthcare Investor Capital Royalty Closes $805M Fund 05/02/13 Texas
Synthetic Biologics, Fuelled by Billionaire, Takes Aim at C.Diff 05/02/13 Detroit
Aveo Shares Plummet as FDA Advisory Panel Votes Down Cancer Drug 05/02/13 Boston
Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS 05/02/13 Texas
Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration 05/02/13 San Diego
NW Biotech Education Group Faces Loss of Federal Money, Deep Cuts 05/02/13 Seattle
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
Natera Grabs $55M For Push into Prenatal Genetic Screening 05/01/13 San Francisco
Texas, and Its Maverick Entrepreneurs, Propel Innovation 05/01/13 Texas
Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S. 04/30/13 National
Supply Chains Are Orderly. Biotech Innovation Is Messy 04/30/13 Boston
Qiagen Buys Ingenuity Systems, Biology Software Player, for $105M 04/29/13 San Francisco
Announcing Xconomy Napa Summit 2013: New Rules for Growth 04/29/13 National
Six Reasons Why Illumina Has Nothing to Fear from Thermo/Life 04/29/13 National
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
Boston: Reclaiming Its Place as a Technology Hub 04/26/13 Boston
Can Biotech Learn From the TV Production Market? 04/26/13 National
East Coast Life Sciences Roundup: Bind, Gen9, Radius, Cydan 04/26/13 Boston
Esperion Therapeutics Raises $33M to Further Clinical Trials 04/25/13 Detroit
Radius Health, Still Private, Raises Another $43M 04/25/13 Boston
Cydan, the NEA Startup Machine, Scours the Globe for Orphan Drugs 04/25/13 Boston
San Diego Life Sciences Roundup: Avalon’s GSK Deal, Illumina, & More 04/25/13 San Diego
Avalon Ventures’ $495M Deal Grew from GSK Quest for Academic Inroads 04/24/13 San Diego
Gen9, Synthetic Biology Startup, Snags $21M from Agilent 04/24/13 Boston
The Devil is in the Details: What BioPharma Press Releases Don’t Say 04/24/13 Seattle
Biotech Execs Aren’t Ready to Prove Drugs Have Value, E&Y Says 04/23/13 National
GlaxoSmithKline and Avalon Ventures Agree to Startup Collaboration 04/22/13 San Diego
Bind Therapeutics, AstraZeneca Collaborate on Cancer Drug 04/22/13 Boston
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Page 2 of 187 « previous page · next page »